These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 28203752

  • 1. Molecular profiles of benign and (pre)malignant endometrial lesions.
    van der Putten LJM, van Hoof R, Tops BBJ, Snijders MPLM, van den Berg-van Erp SH, van der Wurff AAM, Bulten J, Pijnenborg JMA, Massuger LFAG.
    Carcinogenesis; 2017 Mar 01; 38(3):329-335. PubMed ID: 28203752
    [Abstract] [Full Text] [Related]

  • 2. Immunohistochemical and genetic profiles of endometrioid endometrial carcinoma arising from atrophic endometrium.
    Geels YP, van der Putten LJ, van Tilborg AA, Lurkin I, Zwarthoff EC, Pijnenborg JM, van den Berg-van Erp SH, Snijders MP, Bulten J, Visscher DW, Dowdy SC, Massuger LF.
    Gynecol Oncol; 2015 May 01; 137(2):245-51. PubMed ID: 25773202
    [Abstract] [Full Text] [Related]

  • 3. PIK3CA mutations and amplification in endometrioid endometrial carcinomas: relation to other genetic defects and clinicopathologic status of the tumors.
    Konopka B, Janiec-Jankowska A, Kwiatkowska E, Najmoła U, Bidziński M, Olszewski W, Goluda C.
    Hum Pathol; 2011 Nov 01; 42(11):1710-9. PubMed ID: 21531001
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [KRAS mutations analysis in mucinous epithelial lesions of the endometrium].
    Zheng XZ, Zhan Y, Ma JH, Xu HW, Zhi WX, Chen TB, Qin XY, Wang P, Zhang LH, Gu YC, Jin YL, Zhu L, Wu BQ.
    Zhonghua Bing Li Xue Za Zhi; 2018 Sep 08; 47(9):687-690. PubMed ID: 30220122
    [Abstract] [Full Text] [Related]

  • 6. Clinicopathological Characteristics and KRAS Mutation Status of Endometrial Mucinous Metaplasia and Carcinoma.
    Sung JY, Jung YY, Kim HS.
    Anticancer Res; 2018 May 08; 38(5):2779-2786. PubMed ID: 29715099
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Expression of Glut-1 in Normal Endometrium and Endometrial Lesions: Analysis of 336 Cases.
    Němejcová K, Rosmusová J, Bártů M, Důra M, Tichá I, Dundr P.
    Int J Surg Pathol; 2017 Aug 08; 25(5):389-396. PubMed ID: 28381136
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Hypermethylation of RAS effector related genes and DNA methyltransferase 1 expression in endometrial carcinogenesis.
    Liao X, Siu MK, Chan KY, Wong ES, Ngan HY, Chan QK, Li AS, Khoo US, Cheung AN.
    Int J Cancer; 2008 Jul 15; 123(2):296-302. PubMed ID: 18404674
    [Abstract] [Full Text] [Related]

  • 13. PIK3CA missense mutation is associated with unfavorable outcome in grade 3 endometrioid carcinoma but not in serous endometrial carcinoma.
    McIntyre JB, Nelson GS, Ghatage P, Morris D, Duggan MA, Lee CH, Doll CM, Köbel M.
    Gynecol Oncol; 2014 Jan 15; 132(1):188-93. PubMed ID: 24262879
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pathology of endometrioid carcinoma.
    Albertini AF, Devouassoux-Shisheboran M, Genestie C.
    Bull Cancer; 2012 Jan 15; 99(1):7-12. PubMed ID: 22231875
    [Abstract] [Full Text] [Related]

  • 17. High frequency of POLE mutations in synchronous endometrial and ovarian carcinoma.
    Ishikawa M, Nakayama K, Nakamura K, Ono R, Yamashita H, Ishibashi T, Minamoto T, Iida K, Razia S, Ishikawa N, Kyo S.
    Hum Pathol; 2019 Mar 15; 85():92-100. PubMed ID: 30448219
    [Abstract] [Full Text] [Related]

  • 18. [Precursor lesions of endometrial carcinoma: diagnostic approach and molecular pathology].
    Lax S.
    Pathologe; 2011 Nov 15; 32 Suppl 2():255-64. PubMed ID: 22033684
    [Abstract] [Full Text] [Related]

  • 19. Mixed endometrial carcinomas with a "low-grade serous"-like component: a clinicopathologic, immunohistochemical, and molecular genetic study.
    Espinosa I, D'Angelo E, Corominas M, Gonzalez A, Prat J.
    Hum Pathol; 2018 Jan 15; 71():65-73. PubMed ID: 29079180
    [Abstract] [Full Text] [Related]

  • 20. Endometrioid endometrial carcinoma with atrophic endometrium and poor prognosis.
    Geels YP, Pijnenborg JM, van den Berg-van Erp SH, Bulten J, Visscher DW, Dowdy SC, Massuger LF.
    Obstet Gynecol; 2012 Nov 15; 120(5):1124-31. PubMed ID: 23090531
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.